Prothena | Costo Del Venduto



Cost Of Sales Cambiamento Data
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
ALKERMES USD 62.12M 984K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Amgen USD 3.11B 198M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Exelixis USD 19.96M 2.64M 2025-01
Incyte USD 82.38M 2.49M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
MacroGenics USD 5.49M 3.62M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Prothena 970K 4.78M 2024-09
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Prothena Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.